Making ...

VIVES

is an investment fund initiated by UCLouvain which

 

CHALLENGES

SUPPORTS

STRENGTHENS

PERPETUATES

 

your business projects

Key figures

Founded in
2004
Size of Funds under management
90 M €
Investments made
27
Exit
8
Total funds raised
600 M €
Direct jobs created
382

Portfolio

VIVES is a multi-sector fund that invests in projects with a positive societal impact

iTeos Therapeutics targets the tumor microenvironment to boost immune cell efficiency in cancer eradication.

Immunotherapy is a revolutionary approach to cancer treatment that aims to educate the...

Keemotion

Keemotion has developed a motion detection technology. Their proprietary software offers a complete solution for coaches, leagues and broadcasters. Thanks to Keemotion, your organization produces...

Syndesi Therapeutics is building upon a rich legacy of research on SV2A conducted at UCB. UCB identified novel modulators of SV2A that show pro-cognitive properties in preclinical models.

With the...